COMPASS Pathways plc (CMPS) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 37 days, typically, give or take 18 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Tue, Nov 3, 2026before open 34 8-K
Q2 FY2026Wed, Aug 5, 2026before open 36 8-K
Q1 FY2026Wed, May 13, 2026before open 43 8-K
Q4 FY2025Tue, Mar 24, 2026before open 83 8-K
Q3 FY2025Tue, Nov 4, 2025before open 35 8-K
Q2 FY2025Thu, Jul 31, 2025before open 31 8-K
Q1 FY2025Thu, May 8, 2025before open 38 8-K
Q4 FY2024Thu, Feb 27, 2025before open 58 8-K

What they guided beta

Q3 FY2026 "The decrease was primarily driven by lower development expenses, reflecting reduced clinical trial costs following completion of our Phase 3 program for COMP360 psilocybin treatment in TRD, as well as reduced discovery program expenses following the termination of certain programs in connection with the reorganization that took place in the fourth quarter of 2024 and the related contract terminations in 2025." exhibit
Q3 FY2026 "Financial Guidance The current cash position is expected to be sufficient to fund operating expenses and capital expenditure requirements into 2028." exhibit
Q2 FY2026 "Rolling NDA submission and initial review underway and final submission expected to be completed in Q4" exhibit
Q2 FY2026 "Commercial launch expected in first half of 2027" exhibit
Q2 FY2026 "Rolling submission and initial review are underway, with some modules of the NDA submitted and on track to complete all modules in Q4 Support and momentum:" exhibit
Q2 FY2026 "Second half 2026 efforts are centered on operationalizing launch plans and ensuring launch readiness, with commercial launch expected in first half of 2027, subject to FDA approval and following Drug Enforcement Administration (DEA) rescheduling." exhibit
Q2 FY2026 "The decrease was primarily driven by lower development expenses, reflecting reduced clinical trial costs as our Phase 3 program for COMP360 psilocybin therapy in TRD progresses toward completion, as well as reduced discovery program expenses following the termination of certain programs in connection with the reorganization that took place in the fourth quarter of 2024 and the related contract terminations in 2025." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CMPS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CMPS

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

CMPS earnings date badge

HTML

<a href="https://veritasdata.dev/company/CMPS/"><img src="https://veritasdata.dev/embed/CMPS.svg" alt="CMPS earnings date" width="240" height="56"></a>

Markdown

[![CMPS earnings date](https://veritasdata.dev/embed/CMPS.svg)](https://veritasdata.dev/company/CMPS/)

Script

<script async src="https://veritasdata.dev/embed/CMPS.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CMPS"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.